In Brief
This article was originally published in The Tan Sheet
Executive Summary
Takeda makes Brazilian OTC play; Valeant supplements Canadian portfolio; NAD cools Add Lib libido claims; Triu Naturals hedges on ERSP recommendation; Dr. Reddy’s launches lansoprazole; more news In Brief.
You may also be interested in...
Supplement Sustainability Can Sow Competitive Advantage
Much of the dietary supplement industry may be missing the movement toward sustainability in ingredient sourcing. Advocates say adopting practices that consider economic, environmental and social sustainability can make for a more predictable supply chain and more compelling marketing message.
Supplement Sustainability Can Sow Competitive Advantage
Much of the dietary supplement industry may be missing the movement toward sustainability in ingredient sourcing. Advocates say adopting practices that consider economic, environmental and social sustainability can make for a more predictable supply chain and more compelling marketing message.
Perrigo Squares Off With Dr. Reddy’s In Lansoprazole Launch
FDA denied Perrigo’s petition that had sought to block Dr. Reddy’s ANDA for generic Prevacid 24HR because it used bioequivalence data for the proton pump inhibitor’s Rx version. Competition between the firms is intensifying as Dr. Reddy’s expands its U.S. OTC presence.